Background: STIL is a centriole duplication factor that localizes to the procentriolar cartwheel region, and mutations in STIL are associated with autosomal recessive primary microcephaly (MCPH). Excess STIL triggers centriole amplification, raising the question of how STIL levels are regulated. Results: Using fluorescence time-lapse imaging, we identified a two-step process that culminates in the elimination of STIL at the end of mitosis. First, at nuclear envelope breakdown, Cdk1 triggers the translocation of STIL from centrosomes to the cytoplasm. Subsequently, the cytoplasmic bulk of STIL is degraded via the anaphase-promoting complex/cyclosome (APC/C)-proteasome pathway. We identify a C-terminal KEN box as critical for STIL degradation. Remarkably, this KEN box is deleted in MCPH mutants of STIL, rendering STIL resistant to proteasomal degradation and causing centriole amplification. Conclusions: Our results reveal a role for Cdk1 in STIL dissociation from centrosomes during early mitosis, with implications for the timing of cartwheel disassembly. Additionally, we propose that centriole amplification triggered by STIL stabilization is the underlying cause of microcephaly in human patients with corresponding STIL mutations.
Introduction
The STIL gene (or SIL; SCL/TAL1 interrupting locus) was initially cloned in studies of a chromosomal rearrangement causing T cell acute lymphoblastic leukemia [1] and was subsequently shown to be essential for vertebrate embryonic development [2, 3] . Early studies emphasized a role in mitotic regulation [4, 5] , but when the STIL protein was discovered to share localized sequence similarity with Drosophila Ana2 and Caenorhabditis elegans SAS-5 [6] , attention was focused on a possible role of STIL in centriole duplication [7] [8] [9] . Indeed, STIL depletion completely blocks centriole formation, whereas STIL overexpression results in extensive centriole amplification. Furthermore, STIL colocalizes with SAS-6 at the procentriolar cartwheel [8, 9] , a key structure in procentriole assembly (for review, see [10] ).
Mutations in STIL cause autosomal recessive primary microcephaly (MCPH), a neurodevelopmental disorder characterized by reduced brain size. The disease is genetically heterogeneous, with at least ten causative loci identified (MCPH1-MCPH10), and remarkably, nearly all mutated genes code for centrosome-related proteins [11, 12] . Defects in spindle positioning [13, 14] , cell-cycle progression [15] , or DNA repair [16, 17] have been considered as root causes for MCPH. To date, four different STIL mutations have been identified in microcephaly patients [18, 19] , but how these interfere with human brain development is unknown.
In normal cells, levels of STIL need to be precisely controlled in order to prevent abnormal centriole numbers, raising the question of how STIL protein levels are regulated. Previous studies have revealed a proteasome-dependent decline of STIL at mitotic exit [8, 9, 20] . Here we have dissected the mechanisms underlying cell-cycle regulation of STIL at subcellular level, focusing on distinct centrosomal and cytoplasmic protein pools.
Results

Differential Regulation of Cytoplasmic and Centrosomal STIL Pools
To precisely monitor cell-cycle regulation of STIL at the singlecell level, we established a real-time assay based on timelapse fluorescence microscopy. EGFP-tagged STIL was expressed in a U2OS Flp-In T-REx cell line, under control of a tetracycline-inducible promoter. After tetracycline addition for 12 to 24 hr, EGFP-STIL was expressed at near physiological levels (see Figure S1A available online). Immunofluorescence microscopy showed that EGFP-STIL was localized to centrioles ( Figure S1B ), and costaining for SAS-6 confirmed extensive colocalization, in line with previous results [8, 9, 21, 22] . In addition, EGFP-STIL was detectable throughout the cytoplasm. Surprisingly, even prolonged induction of EGFP-STIL expression failed to cause centriole amplification ( Figure S1C ), although transient overexpression of EGFP-STIL (estimated to produce an approximately 15-fold excess) caused supernumerary centrioles in more than 50% of transfected cells, including 20% with flower-like arrangements (Figures S1D-S1F). These results indicate that EGFP-STIL is functional in the tetracycline-inducible U2OS cell line but that its expression occurs at sufficiently low levels to escape centriole amplification. This implies that mild overexpression of STIL (an approximate doubling of levels) is tolerated, at least in these cells ( Figures S1A and S1C) .
Use of a spinning-disk confocal microscope allowed us to monitor both centrosomal and cytoplasmic EGFP-STIL levels for an entire cell cycle (Figure 1 ; Movie S1). These measurements revealed that the cytoplasmic EGFP-STIL signal increased steadily toward mitosis and remained stable throughout prophase, prometaphase, and metaphase but dropped sharply after anaphase onset ( Figures 1A and 1C) . In the next cell cycle, cytoplasmic EGFP-STIL levels remained low in early G1 before they began to rise again 3-4 hr later. A strikingly different pattern was seen when analyzing EGFP-STIL intensity at the centrosome ( Figures  1B and 1C) . Although the centrosomal EGFP signal also increased toward mitosis, it rapidly disappeared from early mitotic centrosomes immediately after nuclear envelope breakdown (NEBD). No centriolar signal was detected in late mitosis and early G1, and relocalization of EGFP-STIL to centrioles was observed only when the cytoplasmic levels began to rise in late G1 and early S phase. Thus, whereas cytoplasmic STIL remains high until anaphase onset, centriolar STIL begins to disappear as early as NEBD, indicating *Correspondence: erich.nigg@unibas.ch that centrosomal and cytoplasmic STIL pools are differentially regulated.
Cdk1 Triggers Removal of Centrosomal STIL
To explore the mechanism underlying loss of STIL from early mitotic centrosomes, we filmed cells from NEBD into metaphase (Figure 2 ; Movies S2 and S3). Consistent with the above results, centrosomal STIL signals began to decrease at NEBD, reaching undetectable levels 15-30 min later, while cytoplasmic STIL intensity remained steady (Figures 2A and 2D ). This loss of centrosomal STIL was not dependent on proteasome activity, as it was not impaired by addition of the proteasome inhibitor MG132 (Figures 2B and 2D ; Figure S2 ). It follows that loss of centrosomal STIL reflects relocalization to the cytoplasm, most likely in response to posttranslational modification. As STIL dissociates from centrosomes at the time when Cdk1 is first activated, we explored a role for this key regulatory kinase in controlling STIL localization. Indeed, when two distinct Cdk1 inhibitors, RO-3306 or roscovitine, were added to cells shortly after entry into mitosis, the centrosomal STIL signal was completely stabilized (Figures 2C and  2E ; Figure S3 ), indicating that activation of Cdk1 at the onset of mitosis triggers dissociation of STIL from centrosomes.
STIL and SAS-6 colocalize at newly forming procentrioles and depend partly on each other for localization [7] [8] [9] , suggesting that both proteins interact at the cartwheel. Thus, we asked whether dissociation of STIL from centrosomes at NEBD might influence centrosomal association of SAS-6 and thereby affect cartwheel stability. Immunofluorescence microscopy was used to carefully compare centrosomal levels of endogenous SAS-6 and STIL in fixed U2OS cells (Figure 3) . Centrosomal SAS-6 levels decreased significantly already upon transit from prophase to metaphase, suggesting that SAS-6 also dissociates from centrosomes at these early stages, albeit with slower kinetics than STIL. Interestingly, STILnegative metaphase centrosomes contained significantly less SAS-6 than those on which traces of STIL could be detected. In early G1 phase, STIL and SAS-6 were undetectable on virtually all centrosomes, as expected [7] [8] [9] 24] . Collectively, these data indicate that STIL stabilizes SAS-6 association with centrosomes or vice versa.
The above results raised the possibility that cartwheel disassembly begins already during early mitosis. Thus, we analyzed centriolar STIL and SAS-6 levels in nocodazolearrested prometaphase cells. Compared to prophase cells, which showed high levels of STIL and SAS-6 at centrosomes, the arrested cells showed reduced levels (Figures S4A and S4B), including 24% of centrosomes on which neither STIL nor SAS-6 could be detected. This suggests that complete loss of the cartwheel can occur as early as prior to spindle checkpoint silencing. Western blotting of cells arrested in nocodazole readily revealed a Cdk1-dependent upshift in STIL, but not SAS-6, pointing to STIL as a likely downstream target ( Figure S4C ). can be activated by exogenous expression of its coactivator Cdh1 [25] . We coexpressed FLAG-STIL with increasing amounts of myc-Cdh1 in human embryonic kidney (HEK) 293T cells and subsequently analyzed FLAG-STIL levels by western blotting. Myc-Cdh1 indeed triggered a drastic decrease in FLAG-STIL levels ( Figure 4C ), confirming that STIL is an APC/C target [9] . A strong effect of Cdh1 was also observed on FLAG-SAS-6, a known substrate of the APC/C [24] (Figure 4D ), but not on EGFP ( Figure 4E ), confirming the specificity of this assay. Next, we used coexpression of Cdh1 with STIL truncations to map the part of STIL that mediates destruction by APC/C. Both the N-terminal and central parts of STIL resisted Cdh1 overexpression, whereas the C-terminal part was degraded ( Figure 4F ). This indicated that the C terminus of STIL harbors a signal for APC/C-mediated degradation, which was corroborated by analysis of STIL mutants lacking either the C or N terminus ( Figure 4G ).
APC/C-mediated degradation of substrate proteins depends on motifs, known as D boxes or KEN boxes, that allow recognition by the APC/C coactivators Cdc20 and Cdh1 [26] . A motif search identified five putative D boxes (RXXL) and one putative KEN box (KEN) within STIL ( Figure 4H ). Alanine substitutions of all potential degradation motifs and coexpression of the mutants with Cdh1 revealed that only mutation of the KEN box conferred significant stabilization ( Figures 4I  and 4J ). The KEN box lies within the C terminus of STIL, in line with our mapping results ( Figures 4F and 4G ), indicating that it is the critical motif mediating APC/C-dependent degradation of human STIL during mitotic exit. Alignment of STIL sequences from different species revealed strong conservation of the KEN box among vertebrates, except for chicken, suggesting utilization of another APC/C degradation motif in this species ( Figure S5 ).
The KEN Box Is Lost in STIL Truncations of Microcephaly Patients
Mutations in the STIL gene have been linked to autosomal recessive primary microcephaly [19] . However, the molecular and cellular defects caused by these mutations are not understood. Given that two truncating mutations seen in patients (p.Gln1239X and p.Val1219X) cause loss of only 49 and 69 amino acids, respectively, from the C terminus of STIL [19] , we were intrigued to find that these truncations remove the KEN box that we have identified here as critical for regulation of STIL stability ( Figure 5A ). This raised the possibility that development of primary microcephaly results from deregulation of STIL protein levels. To explore this provocative link, we first examined the response of the p.Gln1239X and p.Val1219X mutants to coexpression with Cdh1. As expected, both truncations showed substantial resistance to APC/Cmediated degradation ( Figure 5B ). Next, we analyzed the impact of these MCPH mutations on STIL localization and centriole duplication. Much like wild-type STIL, both mutants localized in a ring-like pattern around the central mother centriole, surrounded by an outer ring of the distal protein CP110 associated with multiple daughter centrioles (Figure 5C ). In fact, transient overexpression of both MCPH mutants in U2OS cells promoted centriole amplification to an extent similar to overexpression of wild-type STIL ( Figure 5D ). Together, these results indicate that STIL truncations seen in microcephaly patients do not interfere with either correct localization or functionality of the STIL protein, in line with previous results [7] . Further examination of various deletion mutants revealed that removal of up to 132 amino acids from the STIL C terminus did not detectably interfere with protein localization or potency to trigger centriole amplification (Figures 5E-5G ). In contrast, partial or complete removal of the STAN motif, an evolutionarily conserved region [6] , strongly interfered with correct localization and centriole amplification.
STIL p.Val1219X Causes Centriole Amplification
Having established that STIL mutations seen in microcephaly patients affect cell-cycle regulation of STIL expression, we carried out experiments aimed at uncovering the cellular consequences of STIL deregulation in microcephaly. As no patient material was available, we constructed a U2OS Flp-In T-REx cell line stably expressing EGFP-STIL p.Val1219X and compared its properties to the line expressing STIL WT (Figures 6A and 6B ; Movie S5). STIL p.Val1219X (originally designated as p.Leu1218X) represents a mutation described in two unrelated Indian families [19] . We filmed cells for 5 hr, covering passage from metaphase into the next cell cycle (Figures 6A and 6B ). Within minutes, STIL WT levels fell to around 30%-40% of preanaphase values and then remained low for about 3 hr, before rising again as cells entered late G1/early S phase (see also Figures 1A and 1C) . In stark contrast, cytoplasmic levels of the truncated EGFP-STIL p.Val1219X remained stable throughout the experiment (Figures 6A and  6B ). This demonstrates that EGFP-STIL p.Val1219X resists APC/C-mediated degradation, in line with deletion of the KEN box. On the other hand, filming of cells transiting from NEBD to metaphase showed that STIL p.Val1219X dissociates from early mitotic centrosomes ( Figure S6 ; Movie S6), much like wild-type STIL (Figures 2A and 2D) . We conclude that removal of 69 amino acids from the STIL C terminus in the microcephaly mutant p.Val1219X does not impair Cdk1-regulated dissociation of STIL from early mitotic centrosomes but completely abolishes its degradation in late mitosis. To corroborate the latter conclusion, we compared levels of wild-type and truncated STIL in U2OS Flp-In T-REx cell lines by western blotting. After induction of protein expression by tetracycline for 24, 48, or 72 hr, levels of truncated STIL were significantly higher than those of wild-type STIL at all time points ( Figure 6C ). As both EGFP-STIL WT and EGFP-STIL p.Val1219X are inserted into the same genomic locus, positional effects on protein expression can be largely excluded. Instead, our data indicate that deletion of the KEN box from the p.Val1219X microcephaly version of STIL causes a strong accumulation of this mutant protein.
Finally, and most importantly, the above results raised the question of whether the stabilization of microcephaly mutant STIL might trigger centriole amplification. Having established that expression of wild-type EGFP-STIL in our U2OS Flp-In T-REx model does not cause centriole amplification, because APC/C-mediated degradation limits its accumulation (Figure 1C ; Figure S1C ), we were in a position to ask whether truncation of the KEN box might cause an accumulation of EGFP-STIL p.VAL1219X sufficient to trigger centriole amplification. Thus, both wild-type and mutant STIL proteins were expressed for 24, 48, or 72 hr before cells were stained with anti-CP110 antibodies and centriole numbers counted ( Figures 6D and 6E) . Expression of EGFP-STIL WT did not produce any centriole amplification above background levels, in line with data shown above ( Figure S1C) . In stark contrast, expression of STIL p.Val1219X caused a marked increase in centriole numbers ( Figure 6D ). These results indicate that removal of the KEN box from the p.Val1219X microcephaly mutant version of STIL confers sufficient stabilization to trigger centriole amplification. This invites the attractive hypothesis that microcephaly in human patients carrying the p.Val1219X mutation is caused by the abrogation of STIL cell-cycle regulation.
Discussion
Here we have used time-lapse imaging to analyze the regulation of STIL levels and localization at the single-cell level, with a special focus on traverse of mitosis. Our results lead to two important conclusions. First, we have identified a role for Cdk1 in STIL dissociation from centrosomes during early mitosis, a finding that bears on the cell-cycle regulation of cartwheel disassembly. Second, we have uncovered a provocative mechanistic link to primary microcephaly. We show that a KEN box destruction motif is critical for STIL proteolysis and control of centriole numbers. This motif is deleted in STIL microcephaly truncations, which highlights the importance of orderly STIL cell-cycle regulation and suggests that deregulation of STIL turnover and ensuing centriole amplification constitute the underlying cause of MCPH in the corresponding patients.
A Role for CDK1 in Triggering Cartwheel Disassembly
The cartwheel is a key structural element conferring 9-fold symmetry to nascent centrioles [10] . It is thought to be assembled and disassembled in every cell cycle, but neither the exact timing nor the mechanism underlying cartwheel disassembly is well understood. Here we show that the activation of Cdk1 triggers progressive dissociation of STIL from early mitotic centrosomes. Thus, STIL is likely to be a direct substrate of Cdk1 [4] , although indirect mechanisms are not excluded. We also find that the major cartwheel component SAS-6 is progressively lost from centrosomes upon NEBD, albeit with slower kinetics than STIL. Collectively, our data indicate that Cdk1 activation at NEBD initiates cartwheel disassembly, possibly by phosphorylation of STIL, and that release of both STIL and SAS-6 from mitotic centrosomes precedes their APC/C-dependent degradation at mitotic exit. This proposed two-step mechanism contributes to coordinate cartwheel disassembly with cell-cycle progression.
STIL Is Degraded after Anaphase Onset by the APC/C
Here, we show that STIL is a target of the APC/C, extending our previous observations [9] . By mutational inactivation of all putative D boxes and KEN boxes, we identify the KEN box as the critical degradation motif, indicating that APC/C Cdh1 is The indicated FLAG-STIL constructs and increasing amounts of myc-Cdh1 (0, 2, 4, and 6 mg) were coexpressed for 36 hr in HEK 293T cells before lysates were analyzed by western blotting using indicated antibodies. Empty myc vector was used to equal total amounts of DNA; a-tubulin was analyzed as loading control.
(legend continued on next page) the key driver behind STIL destruction. As single depletion of Cdh1 failed to stabilize STIL [9] , it seems likely that Cdc20 can compensate for the absence of Cdh1, as observed previously for other KEN box-containing Cdh1 substrates [27] . Furthermore, it remains possible that Cdc20 contributes to STIL degradation early after anaphase onset [9] .
STIL Truncations in MCPH Patients Cause Centriole Amplification
Many mutations in genes associated with MCPH are thought to functionally inactivate the corresponding proteins [12] . However, this is not the case for the MCPH-related STIL mutations examined in this study. When transiently overexpressed in U2OS cells, two different MCPH STIL truncations (p.Val1219X and p.Gln1239X) promoted centriole amplification to the same extent as wild-type STIL, attesting to their functionality in centriole biogenesis (see also [7] ). Similar results were obtained (data not shown) with a recently identified MCPH missense mutation termed p.L798W [18] . Thus, we conclude that centriole formation is not fundamentally impaired in the corresponding microcephaly patients. One described MCPH mutation (IVS16DS, G-A, +1) has been proposed to truncate STIL upstream of the STAN motif [19] , but alternative interpretations have not been excluded. As disruption of the STAN motif clearly interferes with STIL function (this study, [7] ), it would be important to examine the functionality of STIL in the corresponding patients. Considering that genetic knockouts of STIL cause embryonic lethality in both mouse and zebrafish [2, 3] , it seems unlikely that complete loss of STIL function would be compatible with life in humans. Instead of causing loss of function, our study reveals that at least two STIL MCPH mutations result in a gain of function. Specifically, these truncations delete a critical KEN box from the C-terminal region of STIL, which leads to STIL stabilization and triggers centriole amplification.
Centriole Amplification, a Root Cause of Microcephaly? Centriole amplification has attracted great interest from the perspective of genome instability and cancer [28] [29] [30] [31] but has not generally been considered a likely mechanism for causing MCPH. Yet, supernumerary centrosomes have been noted in patients or mouse models with mutations in microcephalin (MCPH1), Cep135 (MCPH8), or Cdk5rap2 (MCHP3) [15, 32, 33] . Moreover, a recent study on a mouse model of centriole amplification directly demonstrates that supernumerary centrosomes are able to impair brain development. In this study [34] , centriole amplification was induced in the developing mouse brain by overexpression of Plk4 and was found to result in significantly smaller brains. Interestingly, spindle orientation was not significantly disturbed in Plk4-overexpressing neuroprogenitors. Instead, a high proportion of neuroprogenitors exhibited aneuploidy and underwent apoptosis, providing an attractive alternative explanation for depletion of the neuroprogenitor pool.
Our present data establish a direct link between centriole amplification and STIL mutations in MCPH patients. It will be interesting in future studies to explore whether MCPH mutations in other centriole duplication factors, notably CPAP, Cep135, and Cep152, also affect centriole numbers. Of particular interest in this context is the finding that CPAP interacts with STIL [7, 8] . Moreover, recent studies on the structure of CPAP-STIL complexes suggest that CPAP mutations interfere with STIL binding and centriole biogenesis [35, 36] .
Experimental Procedures
Generation of U2OS Flp-In T-REx Cell Lines U2OS Flp-In T-REx cells were generated according to manufacturer protocols (Invitrogen). To select for transgene integration, we used complete Dulbecco's modified Eagle's medium with 10% tetracycline-free fetal bovine serum (PAA), 5% PenStrep (Invitrogen), 100 mg/ml hygromycin (Invitrogen), and 15 mg/ml blasticidine (Invitrogen).
Cell Culture and Transfections U2OS and HEK 293T cells were grown under standard conditions. Transient transfections were performed with TransIT-LT1 (MirusBio).
Cell Extracts and Western Blots
Cells were lysed in Tris lysis buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.5% IGEPAL CA-630) with protease and phosphatase inhibitors. Polyclonal anti-STIL (Abcam), polyclonal anti-GFP (Abcam), monoclonal anti-myc (Millipore), monoclonal anti-Flag (Sigma), monoclonal anti-hSAS-6 [37] , and mouse anti-a-tubulin (Sigma) were used for western blotting.
Statistical Analysis
All p values were derived from unpaired two-tailed t tests.
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